About this trial
The goal of this clinical trial is to learn if shorter Per-Oral Endoscopic Myotomy (POEM) works as well as a longer POEM in patients with trouble swallowing due to certain conditions. The main question\[s\] it aims to answer \[is/are\]:
* Does making a smaller cut in the muscle at the bottom of the esophagus work just as well as making the standard bigger cut in relieving symptoms? * Does making the smaller cut reduce the side effects of the procedure compared to the standard bigger cut? Researchers will compare the symptoms and side effects of making a shorter cut to the symptoms and side effects of a longer cut.
Participants will allow researchers to access their standard of care information in their medical record, complete questionnaires at up to 6 times over a 2-year period.
Eligibility criteria
Qualifiers
Age ≥ 18
Type I achalasia or type II achalasia or cEGJOO
Eckardt score > 3
Disqualifiers
Prior POEM
Prior surgical treatment for achalasia
Endoscopic pneumatic dilation or lower esophageal sphincter botulinum toxin (botox) injection within 6 months
Prior unrelated esophageal or upper gastric surgery, including Roux-en-Y gastric bypass and sleeve gastrectomy
Trial design
Treatments tested in this trial
- Standard Myotomy
- Tailored Short Myotomy
Treatment groups
Sponsors and collaborators
Northwestern University
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator